Catalent Oral Content
-
Unlocking A Patient Preference For Rapid Onset In Treating Migraines
Examine the case study and learn how formulating an orally disintegrating tablet (ODT) created a convenient dosage form with a shorter Tmax for the treatment of acute migraine.
-
Innovative Softgel Technologies To Deliver Poorly Soluble Molecules
Learn how to expedite the development pathway for early phase compounds and how lipid based formulations provide an innovative approach to enhance bioavailability for challenging molecules.
-
Enhancing Bioavailability For Early Development Phase Molecules
An agile, parallel, and cross-functional approach, powered by a silo-free organization structure, will help in bringing an effective dosage form faster to market. These tools and processes can help.
-
Placing Patients At The Center Of Drug Design
Experts discuss the best time to start thinking about patient centricity, the steps developers can take to achieve patient-centric drug design, and how formulation and dosage forms can make a difference.
-
A Roadmap For Early Development To Commercial Manufacturing
Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.
-
Market Trends, Partnerships Driving Orphan Drug Innovation
This report includes expert guidance on navigating development and manufacturing challenges with orphan drugs, with insights on how drug sponsors of all sizes work with CDMOs to achieve their goals.
-
Amorphous And Co-Amorphous Systems For Poorly Soluble Drugs
Review co-amorphous research and recent findings, particularly the impact of low molecular weight excipient on developability, stability, and solubility.
-
Rapid Developability Assessment Of Early Phase Molecules
A case study illustrating how to use PBPK modeling, the developability classification system, and the biopharmaceutics drug distribution classification system to facilitate development of a molecule.
-
Using Advanced Technologies To Formulate Complex Molecules
In this survey, 200+ people involved in the oral dose market shared their views on barriers to the development of oral formulations and technological responses to them.
-
Strategies For Lipid-Based Drug Delivery Systems And Oral Dosage Forms
Experts share principles, advantages and disadvantages of different dose forms, and considerations for selecting a suitable dosage form for early phase development programs to commercialization.